The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic

Area of Science:

• Cardiology
• Public Health
• Epidemiology

Background:

• The COVID-19 pandemic significantly disrupted healthcare systems globally.
• Cardiovascular disease (CVD) management faced unprecedented challenges during the pandemic.
• Delayed interventions and altered disease trajectories were observed in CVD patients.

Purpose of the Study:

• To summarize key changes in cardiovascular patient phenotypes during the COVID-19 era.
• To identify new clinical challenges in managing cardiovascular conditions post-pandemic.
• To explore potential therapeutic options for evolving cardiovascular patient profiles.

Main Methods:

• Review of clinical observations and management data during the COVID-19 pandemic.
• Analysis of changes in patient presentation and disease progression.
• Synthesis of current literature on cardiovascular care during and after the pandemic.

Main Results:

• Delayed reperfusion in acute coronary syndrome patients.
• Inadequate follow-up and titration for heart failure patients.
• Increased chronicity of atrial arrhythmias due to delayed treatment.
• Emergence of novel cardiovascular patient phenotypes.

Conclusions:

• The pandemic necessitated adaptation in cardiovascular care delivery.
• New patient phenotypes present unique clinical challenges requiring tailored management.
• Future strategies must address the long-term cardiovascular sequelae of the pandemic.